WSJ What's News

The Wall Street Journal

Business, Business News, News & Politics

Chart Positions

Business 30
Business News 3

Stay informed of breaking news throughout your day with senior editor John Wordock of The Wall Street Journal. Listen to critical news and engaging interviews, featuring executives, economists and notable WSJ editors discuss business, markets, the 2016 election and more.


Why Valeant Is Causing Mutual Fund Headaches

March 23rd, 2016

Episode 365 of 886 episodes

Dozens of companies have the Sequoia mutual fund as an investment option in their employee savings plans. But Sarah Krouse of the Wall Street Journal says Sequoia's biggest holding is Valeant Pharmaceuticals; the drugmaker's stock has fallen 70 percent this year over questions about its accounting and business practices.